A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Osteoarthritis of Knee
Interventions
BIOLOGICAL

Cryopreserved Devitalized Adipose Tissue Allograft

BRC-OA is a Cryopreserved Devitalized Adipose Tissue Allograft that has demonstrated anti-inflammatory and antioxidant properties of adipose tissue.

OTHER

Normal Saline (Placebo)

2 mL Normal Saline

Trial Locations (7)

10065

NOT_YET_RECRUITING

Northwell Health, New York

16602

NOT_YET_RECRUITING

University Orthopedics Center, Altoona

16801

NOT_YET_RECRUITING

University Orthopedics Center, State College

20745

RECRUITING

MD Medical Research, Oxon Hill

20874

RECRUITING

Elevate Clinical Research, Rockville

21215

NOT_YET_RECRUITING

LifeBridge Health, Baltimore

21740

RECRUITING

The Osteoporosis & Clinical Trials Center, Hagerstown

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Amarex Clinical Research

OTHER

lead

Britecyte

NETWORK